11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6764/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :06/08/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : "NOVEL VACCINATION CARRIER"<br />

(51) International classification :A61K 39/00 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :30246/2006 1)NIPPON BIOLOGICALS,INC.<br />

(32) Priority Date :07/02/2006<br />

Address <strong>of</strong> Applicant :5-12, KITA AOYAMA 1-<br />

(33) Name <strong>of</strong> priority country :Japan<br />

CHOME,MINTO-KU,TOKYO 107-0061,JAPAN. Japan<br />

(86) International Application No :PCT/JP2007/052079 (72)Name <strong>of</strong> Inventor :<br />

Filing Date<br />

:07/02/2007<br />

1)SHINOBU WATARAI<br />

(87) International Publication No :WO 2007/091580 2)KENJI KONO<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

An object <strong>of</strong> the present invention is to prepare novel vaccine carriers that can be used to produce vaccines that are capable <strong>of</strong> efficient<br />

induction <strong>of</strong> humoral <strong>and</strong> cellular immune responses. Another object <strong>of</strong> the present invention is to provide vaccines that are capable <strong>of</strong><br />

efficient induction <strong>of</strong> humoral <strong>and</strong> cellular immune responses. The present inventors revealed that the above-stated objects <strong>of</strong> the<br />

present invention could be attained by using liposomes containing succinylated poly(glycidol) <strong>and</strong> this finding has led to the<br />

accomplishment <strong>of</strong> the invention. Stated specifically, the present invention can attain the aforementioned objects by providing vaccine<br />

carriers comprising liposomes containing succinylated poly(glycidol).<br />

No. <strong>of</strong> Pages : 75 No. <strong>of</strong> Claims : 22<br />

The Patent Office Journal 24/10/2008 26179

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!